Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,417
datasets available to search
ShareScore release 0.9.0
Dataset results
1,417 results for “triple negative breast cancer”
Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Carboplatin in Triple Negative Breast Cancer (TNBC)
ClinicalTrials.gov study NCT02341911. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Reverse Triple Negative Immune Resistant Breast Cancer
ClinicalTrials.gov study NCT05076682. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Establishment of an ex Vivo Tumor Collection of Triple-negative Breast Cancers in Order to Validate the Interest of Innovative Therapies and the Search for Predictive Biomarkers of Response to Treatme
ClinicalTrials.gov study NCT05404321. IPD Sharing: Not stated. Countries: 1. Publications: 1.
First-Line Sacituzumab Govitecan in Advanced Untreated Triple-Negative Breast Cancer Patients.
ClinicalTrials.gov study NCT07299409. IPD Sharing: NO. Countries: 1. Publications: 4.
BrAin Metastasis in TripLe Negateive Breast Cancer: IvoneScimab and Trop2 ADC
ClinicalTrials.gov study NCT06793332. IPD Sharing: NO. Countries: 1. Publications: 4.
Phase I Study of the Oral PI3kinase Inhibitor BKM120 or BYL719 and the Oral PARP Inhibitor Olaparib in Patients With Recurrent Triple Negative Breast Cancer or High Grade Serous Ovarian Cancer
ClinicalTrials.gov study NCT01623349. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Pembrolizumab and ADG106 in Advanced Solid Cancers and Triple Negative Breast Cancer
ClinicalTrials.gov study NCT05491083. IPD Sharing: NO. Countries: 1. Publications: 3.
Pre-operative Zoledronate in Triple Negative Breast Cancer
ClinicalTrials.gov study NCT02347163. IPD Sharing: NO. Countries: 1. Publications: 16.
Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC)
ClinicalTrials.gov study NCT04799249. IPD Sharing: Not stated. Countries: 11. Publications: 1.
Molecular PD-L1 PET/CT Imaging With 89Zr-atezolizumab in Metastatic Triple Negative Breast Cancer
ClinicalTrials.gov study NCT05742269. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
DCb (Docetaxel/Carboplatin) Versus EC-D (Epirubicin/Cyclophosphamide Followed by Docetaxe) as Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT03154749. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Neoadjuvant Carboplatin in Triple Negative Breast Cancer
ClinicalTrials.gov study NCT02978495. IPD Sharing: UNDECIDED. Countries: 1. Publications: 9.
Ixazomib (MLN9708) in Combination With Carboplatin in Pretreated Women With Advanced Triple Negative Breast Cancer
ClinicalTrials.gov study NCT02993094. IPD Sharing: NO. Countries: 1. Publications: 1.
Evaluate the Clinical Benefit of a Post-operative Treatment Associating Radiotherapy + Nivolumab + Ipilimumab Versus Radiotherapy + Capecitabine for Triple Negative Breast Cancer Patients With Residua
ClinicalTrials.gov study NCT03818685. IPD Sharing: NO. Countries: 1. Publications: 1.
Targeting Triple Negative BREAst Cancer Metabolism With a Combination of Chemoimmunotherapy and a FASTing-like Approach in the Preoperative Setting: the BREAKFAST 2 Trial
ClinicalTrials.gov study NCT05763992. IPD Sharing: NO. Countries: 1. Publications: 15.
Pilot Study To Investigate Targetable Metabolic Pathways Sustaining Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03457779. IPD Sharing: YES. Countries: 1. Publications: 1.
Atezolizumab Combined with Immunogenic Chemotherapy in Patients with Metastatic Triple-negative Breast Cancer
ClinicalTrials.gov study NCT03164993. IPD Sharing: NO. Countries: 2. Publications: 3.
Comparative Study on Two Post-operative Adjuvant Chemotherapy Regimens for Treating Triple-negative Breast Cancer
ClinicalTrials.gov study NCT01642771. IPD Sharing: Not stated. Countries: 1. Publications: 9.
Anti-EGFR-immunoliposomes Loaded With Doxorubicin in Patients With Advanced Triple Negative EGFR Positive Breast Cancer
ClinicalTrials.gov study NCT02833766. IPD Sharing: NO. Countries: 1. Publications: 1.
SKB264 Injection vs Investigator Selected Regimens to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast Cancer
ClinicalTrials.gov study NCT05347134. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.